Suchergebnisse - "Hildebrandt, Martin"

PubPharm (63)

1

Comparison of two autologous hematopoietic stem cell mobilization strategies in patients with multiple myeloma : CE plus G-CSF versus G-CSF only: A single-center retrospective analysis

enthalten in: Transfusion | 2024

von Dill, V. | Blüm, P. | Lindemann, A. | +5

2

Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation

enthalten in: Ophthalmology and therapy | 2023

von Carelli, V. | Newman, N. | Yu-Wai-Man, P. | +126

3

The role of extended coagulation screening in adult cranial neurosurgery

enthalten in: Brain & spine | 2023

von Wagner, A. | Wostrack, M. | Hartz, F. | +5

4

Advanced Therapy Medicinal Products and the Changing Role of Academia

enthalten in: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie | 2022

von Priesner, C. | Hildebrandt, M.

5

Emergency Use of Convalescent Plasma : Perception of the Regulatory Framework from a Clinical Perspective

enthalten in: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie | 2022

von Möhnle, P. | Humpe, A. | Boeck, M. | +4

6

Establishing consensus on ethics, traceability and biovigilance for medical products of human origin

enthalten in: Bulletin of the World Health Organization | 2021

von Ashford, P. | Chapman, J. | Hildebrandt, M. | +4

7

ABO subgroup incompatibility with severe hemolysis after consecutive allogeneic stem cell transplantations

enthalten in: EJHaem | 2021

von Hecker, J. | Wahida, A. | Hameister, E. | +6

8

Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset

enthalten in: Ophthalmology | 2021

von Newman, N. | Yu-Wai-Man, P. | Carelli, V. | +59

CommentIn: Ophthalmology. 2021 May;128(5):661-662. - PMID 33892900

9

Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy : A Randomized Phase II Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Multhoff, G. | Seier, S. | Stangl, S. | +22

10

Horses for courses : an approach to the qualification of clinical trial sites and investigators in ATMPs

enthalten in: Drug discovery today | 2020

von Hildebrandt, M.

1
2
3
4
5
6
7
Nächster »
[7]